Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04485767 · ClinicalTrials.gov registry record · NA
RESIST-ADT (Androgen Deprivation Therapy)
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04485767 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 21 participants.
The verdict
NCT04485767, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The overall goal of this study is to determine if implementing structured exercises prevent decline in muscle mass, muscle strength and physical function in men with prostate cancer undergoing androgen deprivation therapy (ADT). Our main hypothesis is that structured resistance exercise training in men undergoing ADT will preserve physical function assessed by loaded stair climbing power compared with the control group. The trial will also examine the efficacy of the exercise regimen on muscle strength, QOL and fatigue. The findings of this trial will lay the groundwork for definitive intervention trials to prevent frailty and falls in these men.
Interventions
- BEHAVIORAL Progressive Resistance Training Exercise
- BEHAVIORAL Flexibility and Balance Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04485767
The ClinicalTrials.gov registry entry for NCT04485767 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Progressive Resistance Training Exercise is the first listed.
NCT04485767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04485767 about?
NCT04485767 is a clinical study titled "RESIST-ADT (Androgen Deprivation Therapy)". The overall goal of this study is to determine if implementing structured exercises prevent decline in muscle mass, muscle strength and physical function in men with prostate cancer undergoing androgen deprivation therapy (ADT). Our main hypothesis is that structured resistance exercise training in ...
What is the current status of trial NCT04485767?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2020-12-01. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT04485767?
The interventions under investigation include: Progressive Resistance Training Exercise (BEHAVIORAL), Flexibility and Balance Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT04485767?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.